Author: [email protected]

Broadcom Stock Surges on “Massive” AI Growth Prospects

Posted on by [email protected]
Key Points:
– Broadcom (AVGO) shares soared over 20% following strong AI chip revenue projections.
– CEO Hock Tan revealed AI chips could generate up to $90 billion in revenue over three years.
– The company’s market cap surpassed $1 trillion, driven by AI-driven optimism.

Broadcom’s stock skyrocketed over 20% on Friday, hitting an all-time high, after the company unveiled robust expectations for its custom AI chips. CEO Hock Tan highlighted the company’s significant opportunities in the artificial intelligence sector during the latest earnings call, describing the potential revenue from its AI chip business as “massive.”

Tan announced that Broadcom anticipates $60 billion to $90 billion in revenue from its AI chips over the next three years, fueled by demand from three existing hyperscaler customers. While the company declined to name these clients, Tan projected that each would deploy one million clusters of Broadcom’s AI XPUs by 2025. Furthermore, the company confirmed that it has added two new hyperscaler clients who are advancing the development of next-generation AI chips. Industry reports suggest that these new customers may include OpenAI, the creator of ChatGPT, and Apple, both of whom are reportedly exploring custom AI chip solutions to enhance their capabilities and reduce reliance on GPU leader Nvidia.

Broadcom’s share price surged past $220 during Friday’s trading session, boosting its market capitalization to over $1 trillion. The stock’s remarkable rise—up approximately 98% for the year—reflects robust investor confidence in the company’s ability to capitalize on growing demand for AI chips. This surge comes amidst heightened interest in AI technologies, which have become a focal point for tech giants looking to gain competitive advantages.

The company’s financial performance further underscores the significance of its AI initiatives. While Broadcom’s overall semiconductor revenue grew 12% year-over-year to $8.2 billion in the fourth quarter, the numbers reveal a sharp divergence between AI and non-AI segments. Revenue from AI chip sales surged 150% to $3.7 billion, while non-AI semiconductor revenue declined 23% to $4.5 billion. Broadcom’s CEO acknowledged this disparity, emphasizing that the AI semiconductor business will likely outpace the non-AI segment in the coming years.

This trend aligns with broader market dynamics, as the AI chip sector is poised for rapid growth. According to consulting firm International Business Strategies, the AI chip market is projected to expand by 74% in 2025, far outpacing the 12% growth expected for the semiconductor industry as a whole. Analysts believe this trend will persist through the decade as businesses increasingly adopt AI-driven technologies.

Despite these optimistic projections, some analysts exercised caution. Bernstein analyst Stacy Rasgon raised his price target for Broadcom to $250, highlighting the company’s strong performance and potential, but also noted that its high valuation could limit upside potential in the near term. Similarly, Raymond James analyst Srini Pajjuri maintained a neutral stance, citing concerns about Broadcom’s current trading level, which is approximately 33 times its projected fiscal year 2025 earnings.

Broadcom’s achievements reflect its strategic positioning in the AI ecosystem, supported by strong partnerships with leading technology firms. The company’s role in developing advanced chips for data centers, consumer electronics, and enterprise applications ensures its relevance in a competitive landscape. However, challenges persist. While Big Tech companies are investing heavily in AI infrastructure, questions remain about the sustainability of these expenditures, particularly as some firms struggle to monetize AI technologies effectively.

As the industry continues to evolve, Broadcom’s ability to maintain its competitive edge will be crucial. With its innovative AI chip offerings and strategic collaborations, the company is well-positioned to navigate the complexities of a rapidly growing market. Whether it can sustain its momentum amid high expectations remains a pivotal question for investors and industry observers alike.

Top Risks Facing Life Sciences Organizations : Insights from Aon’s Global Risk Management Survey

Posted on by [email protected]

The life sciences sector is currently navigating a complex landscape of evolving and interconnected risks. According to Aon’s recent Global Risk Management Survey, the most pressing concerns for life sciences organizations include supply chain disruptions, cyber attacks, and regulatory changes. These risks are exacerbated by the industry’s heavy reliance on external partners and the need to continuously adapt to new scientific developments and patient needs.

Current Risks

The survey highlighted that supply chain or distribution failure is the top risk facing the industry today. Recent global events have disrupted trade and exposed vulnerabilities in supply chains. The life sciences industry depends heavily on a network of external partners, making it essential for organizations to adopt robust supply chain risk management practices. This includes regular reviews of critical suppliers and comprehensive business continuity planning.

Cyber attacks and data breaches are also a significant concern, ranking as the second-highest risk. The increasing use of digital technologies such as data analytics, the Internet of Things (IoT), and artificial intelligence (AI) in the industry has amplified these risks. Organizations are likely to lose billions globally to cyber attacks in the coming years, underscoring the need for a comprehensive cyber resilience strategy that includes assessment, mitigation, risk transfer, and recovery.

Business interruption, which was the top concern during the height of the COVID-19 pandemic, remains a critical risk but has now fallen to the third position. This shift reflects the ongoing challenges related to supply chain disruptions and the need for organizations to enhance their resilience against such interruptions.

Regulatory or legislative changes are another top concern, ranking fourth among current risks. Changes in government policies, such as those aimed at reducing drug prices or enhancing innovation, can significantly impact the business models of life sciences companies. For instance, recent legislative efforts in the EU and the US are forcing companies to rethink their commercial strategies and prioritize compliance with new regulations.

Failure to attract or retain top talent has emerged as a new critical risk, ranking fifth. The industry is facing a shortage of skilled professionals, particularly in digital fields such as AI and data science. This talent gap is a significant barrier to growth and innovation, highlighting the need for organizations to invest in talent acquisition and retention strategies.

Top 10 Current Risks

  1. Supply Chain or Distribution Failure
  2. Cyber Attack or Data Breach
  3. Business Interruption
  4. Regulatory or Legislative Changes
  5. Failure to Attract or Retain Top Talent
  6. Damage to Brand or Reputation
  7. Product Liability or Recall
  8. Failure to Innovate or Meet Customer Needs
  9. Cash Flow or Liquidity Risk
  10. Capital Availability

Recent global events have pushed these risks to the forefront, making strategic planning and risk management essential components of organizational resilience. Life sciences organizations must continuously monitor and adapt to these evolving risks to maintain their operational and financial stability.

Future Risks

Looking ahead, life sciences organizations anticipate that cyber attacks and data breaches will continue to be a top risk. The increasing digitalization of the industry, coupled with geopolitical volatility, means that cyber threats are likely to remain a persistent challenge. Additionally, the failure to attract or retain top talent is expected to intensify, ranking as the second most significant future risk.

Regulatory or legislative changes are predicted to remain a key issue, rising to the third position in the future. This reflects concerns related to government efforts to manage rising healthcare costs. Supply chain or distribution failure, which is currently the top risk, is expected to drop to the fourth position in the future, potentially due to ongoing efforts to mitigate this risk through improved supply chain resilience practices.

Top 10 Future Risks

  1. Cyber Attack or Data Breach
  2. Failure to Attract or Retain Top Talent
  3. Regulatory or Legislative Changes
  4. Supply Chain or Distribution Failure
  5. Business Interruption
  6. Failure to Implement or Communicate Strategy
  7. Failure to Innovate or Meet Customer Needs
  8. Commodity Price Risk or Scarcity of Materials
  9. Cash Flow or Liquidity Risk
  10. Merger, Acquisition or Restructuring

As the life sciences industry continues to evolve, so too will the risks it faces. Organizations must be proactive in their risk management strategies, ensuring they have the capabilities to assess and mitigate potential losses. This includes adopting comprehensive cyber resilience strategies, improving supply chain risk management, and investing in talent acquisition and retention.

Aon’s survey provides invaluable insights into the current and future risks facing the life sciences sector. For a more detailed exploration of these risks and strategies for mitigating them, read the full article on Aon.com.

Realtors Forecast 6% Mortgage Rates in 2025, Boosting Housing Market Optimism

Posted on by [email protected]
Key Points
– National Association of Realtors forecasts a 6% average for 30-year fixed-rate mortgages in 2025, boosting housing affordability and demand.
– Housing starts projected at 1.45 million, with single-family units leading growth.
– Median existing home price expected to rise to $410,700, with a 2% annual increase in house prices.

The National Association of Realtors (NAR) has forecasted that the average U.S. 30-year fixed-rate mortgage will drop to around 6% in 2025, bringing much-needed relief to homebuyers and potentially reviving a sluggish housing market. This rate decrease is expected to make homeownership more accessible for many prospective buyers, helping to stimulate both new housing construction and sales of previously owned homes.

According to the NAR’s latest projections, the housing market will see about 4.5 million existing home sales in 2025, a slight improvement over current levels. House prices are anticipated to rise by approximately 2%, with the median price for an existing home reaching $410,700. This price increase aligns with the general trend in the market, but the forecasted decline in mortgage rates could provide relief to homebuyers struggling with affordability challenges.

In particular, the NAR’s prediction that mortgage rates will stabilize around 6% offers hope to those shut out of the market due to the higher rates seen in recent years. With the current mortgage rate hovering near 7%, many prospective homebuyers have been unable to afford median-priced homes. If rates do indeed fall to 6%, approximately 6.2 million households will be able to afford homes at the median price, giving a much-needed boost to the housing market. This is a stark contrast to the present situation where higher rates have made it difficult for many to qualify for loans, especially first-time buyers.

Over the past few years, the housing market has been affected by the Federal Reserve’s aggressive monetary policy tightening, which increased borrowing costs and led to a slowdown in home sales. Additionally, the so-called “rate-lock” effect has worsened the supply crunch. Many homeowners with mortgage rates below 5% have been reluctant to list their homes for sale, fearing they won’t be able to find a similarly low rate on a new home. As a result, the market has faced limited inventory, which has driven up home prices and further strained affordability.

To address the lack of available homes, builders have focused on constructing smaller homes, which have appealed to buyers seeking more affordable options. This has led to an increase in new home sales, which are expected to continue rising in 2025, with the NAR projecting 1.45 million housing starts, the bulk of them for single-family units. These new homes could provide much-needed inventory, helping to ease the supply issues that have plagued the market.

Despite the positive outlook for 2025, challenges remain. While mortgage rates are expected to decline, they are still relatively high compared to historical norms, and inventory levels are unlikely to return to pre-pandemic levels anytime soon. This ongoing supply shortage will continue to place upward pressure on prices, making homeownership more difficult for some buyers. Additionally, the affordability gap between different regions will continue to vary, with some markets remaining out of reach for many potential buyers.

Nonetheless, the prospect of lower mortgage rates has sparked optimism in the housing market. A stabilizing rate at 6% could provide the necessary boost to allow more buyers to enter the market, driving both demand for existing homes and new construction. This change would also give homebuilders more confidence to move forward with projects, further stimulating the economy.

The ongoing reduction in mortgage rates, alongside a resilient economy, could help buyers overcome affordability barriers, especially in more moderately priced markets. As 2025 approaches, all eyes will be on mortgage rates and the broader housing market to see if these predictions hold true and bring about a much-needed shift toward recovery.

CPI Data Confirms Fed’s December Rate Cut Path

Posted on by [email protected]
Key Points:
– Consumer Price Index (CPI) rose 2.7% year-over-year in November, meeting economist expectations.
– Core inflation remains elevated at 3.3% annually, driven by higher shelter and service costs.
– Markets now strongly anticipate a 25-basis-point Federal Reserve rate cut in December.

The Bureau of Labor Statistics released November inflation data on Wednesday, showing consumer prices increased 2.7% year-over-year. This uptick from October’s 2.6% rise aligns with economist projections and solidifies expectations for the Federal Reserve to lower interest rates at its December meeting.

On a monthly basis, the CPI increased by 0.3%, the largest gain since April. Core inflation, excluding volatile food and energy prices, also rose 0.3% month-over-month and 3.3% annually for the fourth consecutive month. Sticky inflation in core components such as shelter and services continues to challenge the Federal Reserve’s goal of achieving a 2% inflation target.

Paul Ashworth, Chief North America Economist at Capital Economics, commented on the persistence of core inflation, noting that it remains a concern but is unlikely to derail the anticipated rate cut. “We don’t expect it to persuade the Fed to skip another 25bp rate cut at next week’s FOMC meeting,” he stated.

Shelter Inflation Moderates, Food Costs Persist

Shelter inflation contributed nearly 40% of the monthly CPI increase, though the annual gain of 4.7% marked a deceleration from October’s 4.9%. Both rent and owners’ equivalent rent showed their smallest monthly increases since mid-2021, suggesting potential relief in housing costs.

Meanwhile, food prices remain a sticky category for inflation. The food index rose 0.4% month-over-month, with notable increases in categories like eggs, which surged 8.2% in November after declining in October. Energy prices also edged higher, rising 0.2% month-over-month, while apparel and personal care costs saw noticeable gains.

Market and Policy Implications

Financial markets reacted positively to the CPI report, as fears of an upside surprise were unfounded. The odds of a 25-basis-point rate cut at the Fed’s December meeting increased to 97% following the release. However, economists remain cautious about potential inflationary pressures stemming from President-elect Donald Trump’s proposed policies, including tariffs and corporate tax cuts.

Seema Shah, Chief Global Strategist at Principal Asset Management, noted the Federal Reserve’s likely shift toward a more cautious approach after December. “We expect the Fed to move off autopilot in January, adopting a more cautious tone, and slowing its pace of cuts to just every other meeting,” Shah said.

As inflation trends remain in focus, the Federal Reserve’s decisions in the coming months will be critical in shaping the economic outlook for 2025.

Candel Therapeutics Stock Skyrockets 172% After Promising Phase III Prostate Cancer Trial Results

Posted on by [email protected]
Key Points:
– Candel Therapeutics’ stock surged 172% after its Phase III trial of CAN-2409 for localized prostate cancer met its primary endpoint.
– The trial showed a 14.5% relative improvement in disease-free survival compared to placebo, with promising long-term results.
– The company plans to use Phase III data to seek regulatory approval from the FDA for CAN-2409.

Candel Therapeutics (CADL) has seen its stock price surge by 172% following the announcement of positive results from its Phase III clinical trial of CAN-2409, a viral immunotherapy designed for localized prostate cancer. This breakthrough was announced on December 11, 2024, signaling the potential of CAN-2409 as a new treatment option for patients battling prostate cancer.

The Phase III trial, conducted under a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA), tested CAN-2409 in combination with radiation therapy and the antiviral drug valacyclovir. The trial showed a statistically significant improvement in disease-free survival, with patients experiencing a 14.5% relative increase in survival compared to the placebo group after 54 months of observation. These results demonstrate the treatment’s ability to improve long-term outcomes for prostate cancer patients.

In addition to the survival benefit, the study also found an increased proportion of patients achieving a prostate-specific antigen (PSA) level associated with remission, further supporting CAN-2409’s potential as a promising treatment. The therapy works by stimulating the immune system to attack prostate cancer cells, offering a novel approach compared to traditional treatments, which often rely on chemotherapy or radiation alone. Importantly, the treatment demonstrated no new safety concerns, with a safety profile similar to that of existing therapies.

The company’s CEO, Paul Peter Tak, expressed confidence in the results, emphasizing that the Phase III trial validated earlier observations of CAN-2409’s effectiveness in hard-to-treat tumors. Tak noted that the study’s design, agreed upon by the FDA, could allow Candel to seek regulatory approval for CAN-2409 as a treatment for localized prostate cancer.

Dr. Glen Gejerman, the principal investigator of the study, highlighted the clinical significance of the results, noting that the improvement in disease-free survival could mark a major advancement in prostate cancer care. Gejerman also pointed out that CAN-2409 offers a treatment option without introducing substantial toxicity, which is a key concern for many prostate cancer therapies.

Candel Therapeutics now plans to use the data from this Phase III trial to advance its marketing application to the FDA. If approved, CAN-2409 could provide a much-needed treatment alternative for patients with localized prostate cancer, transforming the current treatment paradigm.

This success positions Candel as a leader in the prostate cancer space, with investors reacting positively to the trial’s results. The company’s stock price has risen significantly, reflecting growing confidence in its future prospects.

Candel’s success comes at a time when other companies in the prostate cancer field, such as Arvinas and Pfizer, are also advancing their own treatments. However, the dramatic stock increase following the Phase III results highlights the excitement surrounding CAN-2409 and its potential to change the landscape of prostate cancer treatment.

As the company moves toward FDA approval, the oncology community will be watching closely. If successful, CAN-2409 could become a game-changing option for prostate cancer patients, offering new hope and a more effective treatment strategy.

Google Stock Surges Following Quantum Computing Breakthrough

Posted on by [email protected]
Key Points:
– Google’s Willow chip solves complex equations in minutes, outperforming classical supercomputers by billions of years.
– The breakthrough reduces error rates in quantum systems, a major step toward practical applications in cybersecurity, energy, and medicine.
– Alphabet stock is up 30% year-to-date, with a 4% jump following the announcement of Willow.

Google’s stock (GOOG) surged 4% on Tuesday following the announcement of its new quantum computing chip, Willow. The groundbreaking chip, revealed Monday, promises to revolutionize computing by outperforming traditional systems on an unprecedented scale. According to Google, Willow can solve complex equations in just five minutes—calculations that would take a classical supercomputer longer than the history of the universe to complete.

Quantum computing represents a major technological leap, relying on qubits instead of the binary bits used in classical systems. Unlike bits, which can only represent a 0 or a 1, qubits can exist in both states simultaneously. This characteristic enables quantum computers to process vastly more data at once, making them ideal for solving problems that conventional computers cannot.

However, the potential of quantum computing has been hampered by significant challenges. Qubits are prone to errors, which increase as the number of qubits used grows. Google’s Willow chip addresses these challenges, reducing error rates while increasing the number of operational qubits. This advancement brings the industry closer to achieving practical applications for quantum computing.

Google’s announcement not only reaffirms its leadership in the quantum computing race but also highlights its competition. Industry giants like IBM, Microsoft, and Amazon have invested heavily in quantum technology, each vying to lead in the next wave of computing. IBM has been working on quantum systems since the 1980s, while Amazon and Microsoft are integrating quantum capabilities into their cloud platforms.

The potential applications of quantum computing are vast, spanning industries such as healthcare, energy, and cybersecurity. Quantum systems could accelerate drug discovery, develop new renewable energy technologies, and create more robust cybersecurity measures. While these applications remain largely theoretical, Google’s advancements with Willow mark significant progress toward turning them into reality.

The unveiling of Willow has had a tangible impact on investor sentiment. Alphabet’s stock rose as much as 6% early Tuesday before stabilizing at a 4% gain, contributing to a 30% year-to-date increase in the stock. This growth reflects investor confidence in Google’s ability to stay at the forefront of innovation.

Governments worldwide are also ramping up investments in quantum computing. The U.S. has pledged billions of dollars toward research through initiatives like the CHIPS and Science Act. Most recently, bipartisan senators introduced legislation to allocate an additional $2.7 billion to support quantum computing projects. Meanwhile, China leads global spending, investing over $15 billion in quantum research.

Despite the optimism, experts predict fully fault-tolerant quantum computers—systems ready for widespread practical use—may not emerge until after 2035. However, companies like Google are betting on a faster timeline. Willow’s launch demonstrates that the race to quantum supremacy is not just theoretical but an active competition with transformative stakes.

As Google continues to push boundaries with Willow, the company’s leadership in quantum computing solidifies its reputation as an innovation powerhouse. This milestone not only positions Google at the cutting edge of technology but also strengthens its standing in the global race to unlock the full potential of quantum computing.

Gen Digital to Acquire MoneyLion, Expanding into Financial Wellness

Posted on by [email protected]
Key Points:
– Strategic Expansion: Gen Digital is acquiring MoneyLion for $1 billion, extending its services to include financial wellness alongside cybersecurity and identity protection.
– Enhanced Capabilities: The acquisition brings MoneyLion’s 18 million customers and its innovative financial tools into Gen’s ecosystem, offering a seamless blend of fintech and digital security solutions.
– Future Impact: The deal aligns with Gen’s fiscal goals and reinforces its commitment to empowering consumers to manage, grow, and secure their digital and financial lives.

Gen Digital Inc. (NASDAQ: GEN), a global leader in digital safety and privacy solutions, announced a landmark agreement to acquire MoneyLion Inc. (NYSE: ML), a prominent financial technology platform. The acquisition is valued at approximately $1 billion and marks a strategic expansion of Gen’s offerings to include tools for financial wellness alongside its existing suite of cybersecurity and identity protection services.

With this acquisition, Gen extends its mission of empowering consumers to protect, manage, and grow their digital and financial lives. MoneyLion, known for its innovative digital ecosystem, delivers a comprehensive suite of personal finance tools, including credit-building services, financial management features, and a curated marketplace of financial solutions. By integrating MoneyLion into its portfolio, Gen strengthens its position as a provider of holistic digital and financial empowerment.

Vincent Pilette, CEO of Gen Digital, highlighted the significance of the acquisition, stating, “Gen is committed to protecting people’s privacy, identity, and financial assets so they can live their digital lives securely. By bringing MoneyLion into the Gen family, we’re not only safeguarding what people already have, but also enabling them to better manage and grow their wealth.”

MoneyLion’s platform, with over 18 million customers, enhances Gen’s consumer base while introducing new capabilities, such as its AI-driven recommendation engine, which can be leveraged across Gen’s existing offerings. The acquisition also enables Gen to provide its global audience with access to MoneyLion’s robust financial tools, merging innovative fintech solutions with trusted cybersecurity services.

Dee Choubey, Co-Founder and CEO of MoneyLion, expressed enthusiasm for the partnership, emphasizing the alignment of both companies’ missions. “MoneyLion has built a platform that empowers people to take control of their financial futures with confidence. Joining Gen accelerates our vision by leveraging their global reach and trusted brands. Together, we’re creating unmatched value for consumers, empowering smarter financial decisions while securing their digital and financial lives.”

The transaction involves an all-cash offer of $82 per share for MoneyLion shareholders, alongside contingent value rights (CVRs) linked to Gen’s stock performance. Shareholders may receive additional payments of $23 per share if specific stock price targets are achieved within a defined period post-acquisition. While the deal has been unanimously approved by the boards of both companies, it is subject to regulatory approvals and is expected to close in the first half of Gen’s fiscal year 2026.

Gen confirmed that the acquisition aligns with its financial strategy and will not impact its fiscal year 2025 guidance. The company remains committed to maintaining a net leverage ratio below 3x EBITDA by FY27 and expects the acquisition to contribute positively to its adjusted earnings per share.

The acquisition underscores Gen’s commitment to delivering cutting-edge solutions that address the interconnected nature of digital and financial security. By integrating MoneyLion’s capabilities, Gen is poised to redefine how consumers navigate their digital and financial lives with confidence and security.

Bit Digital (BTBT) – November Production Numbers Are In

Posted on by [email protected]


Monday, December 09, 2024

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

HPC and AI. As of November 30, 2024, Bit Digital had 266 servers actively generating revenue and earned approximately $4.3 million of total unaudited GPU Cloud revenue during the month. At Enovum’s data center, the Company had 13 customers actively generating revenue with colocation revenue of approximately $503,500. We believe the Boosteroid agreement, along with the two MSAs signed in the third quarter should expand revenue in the coming months.

Mining Side. The Company produced 44.9 BTC in the month, a 14.0% decrease from 52.2 BTC in October. The active hash rate was 2.51 EH/s, a slight increase from 2.43 EH/s last month. Bit Digital’s hosting provider, Coinmint, being acquired resulted in the termination of hosting contracts. Management has signed term sheets for the lost hosting capacity and is replacing energy inefficient miners, with a 3.0 EH/s active hash rate expected by the first half of 2025.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

DLH Holdings (DLHC) – New Administration Brings More Opportunity

Posted on by [email protected]


Monday, December 09, 2024

DLH delivers improved health and readiness solutions for federal programs through research, development, and innovative care processes. The Company’s experts in public health, performance evaluation, and health operations solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, advanced analytics, cloud-based applications, telehealth systems, and more. With over 2,300 employees dedicated to the idea that “Your Mission is Our Passion,” DLH brings a unique combination of government sector experience, proven methodology, and unwavering commitment to public health to improve the lives of millions. For more information, visit www.DLHcorp.com.

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

4Q Results. Reported revenue was $96.4 million compared to $101.5 million from last year and below our $101 million estimate. Net income for the quarter was $2.3 million, or $0.16/sh, compared to a net loss of $2.6 million, or $0.18/sh, last year. Adjusted EBITDA was $10.7 million, down from $12.1 million last year but above our estimate of $10.5 million.

CMOP. Management noted that the Company’s CMOP portfolio is under new task orders that go into the second quarter of 2025. Significantly, the Company has not continued its joint venture bids for specific locations, citing performance dilution. We expect DLH to bid on fewer CMOP contracts, resulting in lower CMOP revenue, likely once past the current extension.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Kelly Services (KELYA) – Another $50 Million Share Repurchase Authorized

Posted on by [email protected]


Monday, December 09, 2024

Kelly (Nasdaq: KELYA, KELYB) connects talented people to companies in need of their skills in areas including Science, Engineering, Education, Office, Contact Center, Light Industrial, and more. We’re always thinking about what’s next in the evolving world of work, and we help people ditch the script on old ways of thinking and embrace the value of all workstyles in the workplace. We directly employ nearly 350,000 people around the world and connect thousands more with work through our global network of talent suppliers and partners in our outsourcing and consulting practice. Revenue in 2021 was $4.9 billion. Visit kellyservices.com and let us help with what’s next for you.

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

New Authorization. Kelly’s Board of Directors approved a new share repurchase program, authorizing the Company to purchase up to $50 million of its Class A common stock. The authorization expires on December 2, 2026. Shares under the authorization may be purchased from time to time in the open market, in privately negotiated transactions, or by other means.

Size. The $50 million authorization represents approximately 10% of Kelly’s current Class A market capitalization. We believe any potential share repurchases will be balanced against continued paydown of debt, additional M&A opportunities, and re-investment in the business to drive organic growth.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Schwazze (SHWZ) – Update on Accounting

Posted on by [email protected]


Monday, December 09, 2024

Schwazze (OTCQX:SHWZ, NEO:SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to take its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale. The Company is committed to unlocking the full potential of the cannabis plant to improve the human condition. Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector. Schwazze is passionate about making a difference in our communities, promoting diversity and inclusion, and doing our part to incorporate climate-conscious best practices.

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Update. Schwazze, in conjunction with its new auditors, has determined that its financial statements for the two fiscal years ended December 31, 2023, will be restated due to the identification of certain accounting adjustments needed primarily relating to technical accounting areas. The Company filed an 8-k describing the necessary adjustments.

Impact. Although mostly related to technical accounting areas, the Company has concluded that the impact of these corrections is material and, therefore, worthy of restatement. However, Schwazze does not currently believe that the foregoing corrections will have any negative material impact on the Company’s revenue, adjusted EBITDA, cash from operations, or cash position.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

NobleCon20 Recap : Investment Opportunities and Industry Innovation

Posted on by [email protected]

This past week, NobleCon20 brought an electrifying wave of innovation and inspiration to Boca Raton. Hosted by Noble Capital Markets, the event marked its 20th year of connecting growth-oriented companies with forward-thinking investors, entrepreneurs, and thought leaders. Over two days, attendees were treated to dynamic presentations, exciting competitions, and unparalleled networking opportunities, making this year’s NobleCon an unforgettable experience.

Day 1: AI Takes Center Stage and a Disco-Themed Hangar Party

Artificial Intelligence was one of the central themes of NobleCon20, setting the tone for what the future holds for businesses and industries. The day kicked off with an awe-inspiring keynote by Zack Kass, who delved into the transformative power of AI in sectors like healthcare, finance, and consumer goods. His insights into ethical considerations and practical opportunities left attendees eager to harness AI-driven innovation in their fields.

The AI panel, moderated by Noble Capital Markets’ Director of Research, Michael Kupinski, further explored the topic with industry leaders Jon Cohen (ServiceNow), Vin Singh (Bullfrog AI), and Elycia Morris (Synergist). Their engaging discussion covered challenges in AI adoption, emerging trends, and its impact across industries. The diverse perspectives of these experts left attendees with actionable insights to apply within their own organizations.

Throughout the day, the action continued with presentations from over 80 public companies, each showcasing their growth strategies and innovations to intrigued investors eager to learn about new opportunities. These sessions offered a unique chance to connect directly with industry leaders and gain insights into emerging investment trends.

As Day 1 came to a close, the energy shifted to the disco-themed hangar party. Set in a unique aviation venue, the event brought attendees together for a vibrant evening of celebration and networking. With lively music, fantastic food, and a dazzling disco atmosphere, the hangar party was a highlight of the conference, offering a perfect mix of fun and meaningful connections.

Day 2: Shark Tank Stars and Closing the Conference with a Bang

The excitement carried over into Day 2, where the packed schedule continued with more company presentations that kept investors captivated. Each session provided an in-depth look into growth sectors, helping attendees discover potential opportunities in an increasingly dynamic market.

The conference culminated in a grand finale: the Shark Live Pitch Competition. Entrepreneurs took the stage to pitch their innovative startups to the iconic Sharks from Shark Tank—Daymond John, Robert Herjavec, and Kevin O’Leary. The room was electrified as the Sharks asked incisive questions, provided candid feedback, and negotiated deals live. Audience participation added to the excitement, making it a thrilling end to an extraordinary event. The competition highlighted the incredible talent of participating entrepreneurs and underscored the Sharks’ unmatched expertise.

Looking Back at NobleCon20

NobleCon20 delivered on every front, from cutting-edge discussions about AI to thrilling live pitch competitions and unforgettable networking events. It was a celebration of innovation, entrepreneurial spirit, and collaboration, reinforcing Noble Capital Markets’ commitment to fostering growth and success in emerging industries.

Stay tuned for more updates and opportunities from the Noble Capital Markets team as we continue to connect, innovate, and inspire.

Watch the Replays from NobleCon20

Novolex to Acquire Pactiv Evergreen in $6.7 Billion Packaging Industry Merger

Posted on by [email protected]
Key Points:
– All-cash transaction creates leading food and beverage packaging manufacturer
– Combines 250+ brands and 39,000 SKUs across diverse packaging substrates
– 49% premium to Pactiv Evergreen’s pre-announcement stock price

Novolex and Pactiv Evergreen have announced a transformative $6.7 billion merger that will create a leading manufacturer in food and beverage packaging. The all-cash transaction, valued at $18.00 per Pactiv Evergreen share, represents a 49% premium to the company’s recent trading price.

The strategic combination brings together two complementary businesses, establishing an extensive packaging solutions provider with a comprehensive North American manufacturing and distribution network. By merging their portfolios, the companies will offer more than 250 brands and 39,000 product SKUs across multiple packaging substrates, including fiber, resin, and post-consumer recycled content.

Stan Bikulege, Novolex’s Chairman and CEO, emphasized the strategic rationale, highlighting the merger’s potential to create an innovative, sustainable, and customer-focused company. The transaction aims to accelerate product innovation, improve customer service, and enhance sustainability efforts through combined research and development capabilities.

The deal is backed by funds managed by Apollo and Canada Pension Plan Investment Board (CPP Investments), which will contribute approximately $1 billion and become a significant minority shareholder. Upon completion, expected in mid-2025, Pactiv Evergreen will become a privately held company.

Key strategic benefits include expanded service capabilities across the U.S., Canada, and Mexico, and increased resources for developing recyclable, compostable, and reusable packaging. The merger positions the combined entity to better meet evolving customer demands in grocery, retail, restaurant, and foodservice markets.

Michael King, Pactiv Evergreen’s President and CEO, described the transaction as a milestone that maximizes shareholder value and represents the next exciting chapter for the company. The merger builds on both companies’ recent operational improvements and focus on product innovation.

The transaction has received approval from Pactiv Evergreen’s Board of Directors and is subject to regulatory approvals and customary closing conditions. Upon completion, Novolex’s leadership will guide the combined organization, leveraging the strengths of both companies to create a packaging industry leader.